Modular transcriptional repertoire analyses identify neutrophil signature as candidate biomarker for lupus nephritis. Homo sapiens

Gene expression profiling (compared to healthy controls) to identify a biomarker for lupus nephritis Overall design: 157 “SLE”, 20 “Healthy controls of SLE, 25 Control of Kidney Disease, 21 Healthy control of sepsis, and kidney disease, and 15 ICU Controls, were followed up for up to 3 years. Clinical assessment, current treatment, laboratory results and SLEDAI score were collected at each visit (V1, V2...). SLE patients are compared to control groups.